News
06-14-2013, 04:50 AM
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.
More... (http://www.news-medical.net/news/20130614/Genetic-variations-may-help-predict-breast-cancer-risk-in-women-who-receive-preventive-therapy.aspx)
More... (http://www.news-medical.net/news/20130614/Genetic-variations-may-help-predict-breast-cancer-risk-in-women-who-receive-preventive-therapy.aspx)